Melina E. Marmarelis

机构：Penn Center for AIDS Research, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania · ORCID：0000-0003-2187-3583

发表论文 136 篇 · 总被引 1938 次 · h-index 22

代表论文

• Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study (2025 · European Journal of Cancer · 被引 6)
• Amivantamab Plus Lazertinib in Atypical EGFR -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2 (2025 · Journal of Clinical Oncology · 被引 5)
• Overall survival of first-line amivantamab plus lazertinib in atypical EGFR -mutated advanced non-small cell lung cancer (NSCLC): Updated results from the CHRYSALIS-2 study. (2026 · Journal of Clinical Oncology · 被引 3)
• Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) (2026 · Lung Cancer · 被引 2)
• Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy (2025 · American Journal of Clinical Oncology · 被引 2)
• Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC (2025 · JTO Clinical and Research Reports · 被引 2)